NewAmsterdam Pharma Co N.V.
Ticker: 1936258
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 3.70+21.7% | 3.04+768.6% | 0.35-98.2% | 19.15+542.6% | 2.98-89.8% | 29.11+1176.8% | 2.28+62.9% | 1.40 |
| Total Income | 3.70+21.7% | 3.04+768.6% | 0.35-98.2% | 19.15+542.6% | 2.98-89.8% | 29.11+1176.8% | 2.28+62.9% | 1.40 |
| EXPENSES | ||||||||
| Expenditure | 68.57+11.6% | 61.46+10.8% | 55.49+1.3% | 54.78-23.8% | 71.90+32.9% | 54.11-1.3% | 54.85-3.6% | 56.88 |
| Tax | — | — | — | — | — | 0.00 | — | — |
| PROFIT | ||||||||
| PBT | -64.14-32.4% | -48.44+32.7% | -72.01-314.8% | -17.36+56.1% | -39.53-137.4% | -16.65+57.3% | -39.01+58.4% | -93.77 |
| Net Profit | -64.14-32.4% | -48.44+32.7% | -72.01-314.8% | -17.36+56.1% | -39.53-137.4% | -16.65+57.3% | -39.01+58.4% | -93.77 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-14.11pp | -85.89%+14.11pp | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00%-9.30pp | -90.70%+9.30pp | -100.00%-42.81pp | -57.19%+42.81pp | -100.00% | -100.00% |
| EPS | -0.52-30.0% | -0.40+34.4% | -0.61-306.7% | -0.15+55.9% | -0.34-88.9% | -0.18+56.1% | -0.41+61.3% | -1.06 |
Corporate Events
Board MeetingNAMS
202614Aug
Board Meeting
Douglas Kling resigns as Chief Operating Officer, effective …
SEC Filing ↗ Board MeetingNAMS
20265Aug
Board Meeting
NewAmsterdam Pharma to host an Investor Day event for analys…
SEC Filing ↗ Board MeetingNAMS
20262Jun
Board Meeting
Annual General Meeting to consider the adoption of 2025 annu…
SEC Filing ↗ Board MeetingNAMS
202620Apr
Board Meeting
Officer Separation - Ms. Kooij's departure and compensatory …
SEC Filing ↗